Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dth.14660 http://scihub22266oqcxt.onion/10.1111/dth.14660 33301216!ä!33301216 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\33301216.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Dermatol+Ther 2021 ; 34 (1): e14660 Nephropedia Template TP {{tp|p=33301216|t=2021. New generation biologics for the treatment of psoriasis and psoriatic arthritis State of the art and considerations about the risk of infection |pdf=|usr=}}{{33301216}} gab.com Text New generation biologics for the treatment of psoriasis and psoriatic arthritis State of the art and considerations about the risk of infection JO: Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=33301216 #FOAvip Psoriasis is a chronic immune-mediated disease characterized by inflammation of skin (psoriasis) or joints (psoriatic arthritis) or both, resulting from a dysregulation in particular of the T helper (Th)17 functions. There is no available cure for psoriasis, and a life-long treatment is needed to control signs and symptoms. Research interest is high around the newest biological drugs approved for the treatment of moderate to severe psoriasis and psoriatic arthritis, and especially drugs blocking the IL-23/IL-17 axis. Our aim is to review the new biological drugs for the treatment of psoriasis and their adverse effects, focusing on the risk of infections. Twit Text FOAVip New generation biologics for the treatment of psoriasis and psoriatic arthritis State of the art and considerations about the risk of infection ????Dermatol Ther http://www.kidney.de/pget.php?&tw=1&pmid=33301216 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33301216 #FOAvip English Wikipedia <ref>{{Cite pmid|33301216}}</ref> New generation biologics for the treatment of psoriasis and psoriatic arthritis State of the art and considerations about the risk of infection #MMPMID33301216 Ceccarelli M; Venanzi Rullo E; Berretta M; Cacopardo B; Pellicano GF; Nunnari G; Guarneri C Dermatol Ther 2021[Jan]; 34 (1): e14660 PMID33301216show ga Psoriasis is a chronic immune-mediated disease characterized by inflammation of skin (psoriasis) or joints (psoriatic arthritis) or both, resulting from a dysregulation in particular of the T helper (Th)17 functions. There is no available cure for psoriasis, and a life-long treatment is needed to control signs and symptoms. Research interest is high around the newest biological drugs approved for the treatment of moderate to severe psoriasis and psoriatic arthritis, and especially drugs blocking the IL-23/IL-17 axis. Our aim is to review the new biological drugs for the treatment of psoriasis and their adverse effects, focusing on the risk of infections. |*Arthritis, Psoriatic/diagnosis/drug therapy[MESH] |*Psoriasis/diagnosis/drug therapy[MESH] |Biological Products/adverse effects/*therapeutic use[MESH] |Humans[MESH] |Inflammation[MESH]New generation biologics for the treatment of psoriasis and psoriatic (epmc).pdf DeepDyve Pubget Overpricing